BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 34938422)

  • 1. Application of Evidence-Based Nursing Intervention in the Treatment of Advanced Squamous Cell Carcinoma of the Lung by Erlotinib Combined with Tegafur, Gimeracil, and Oteracil Potassium and Its Influence on Quality of Life.
    Liu S; Huang X; Wen J; Fu F; Wang H
    J Healthc Eng; 2021; 2021():6801779. PubMed ID: 34938422
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficacy and safety of S-1 (tegafur, gimeracil, and oteracil potassium) concurrent with 3-dimensional conformal radiotherapy for newly diagnosed squamous cell carcinoma of the lung in elderly patients.
    Wang T; Zhang SF; Qiu MQ; Li QL
    Cancer Radiother; 2016 May; 20(3):181-6. PubMed ID: 27068497
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Clinical Evaluation of Tegafur Gimeracil Oteracil Combined with THP and DDP for Second-Line Treatment of Advanced Cardiac Carcinoma.
    Wang HF; Lv JQ
    Cell Biochem Biophys; 2015 Jul; 72(3):695-9. PubMed ID: 25618173
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy of apatinib combined with tegafur gimeracil and oteracil potassium in the second-line treatment of advanced gastric cancer.
    Chen H; Xue L; Liu L; Li P
    J BUON; 2021; 26(3):917-923. PubMed ID: 34268954
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effectiveness and safety of tegafur-gimeracil-oteracil potassium (TS-1) for metastatic breast cancer: a single-center retrospective study.
    Ishizuna K; Ninomiya J; Ogawa T; Kojima M; Tsuji E; Kawashima M; Nozaki M; Yamagishi H; Ueda Y
    Gan To Kagaku Ryoho; 2014 Dec; 41(13):2577-82. PubMed ID: 25596051
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Analysis of Rehabilitation Effect of Neurology Nursing on Stroke Patients with Diabetes Mellitus and Its Influence on Quality of Life and Negative Emotion Score.
    Yang Y; Niu G; Mi Q; Hong F; Zhang G
    Dis Markers; 2022; 2022():1579928. PubMed ID: 35308141
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Safety of alternate-day treatment with TS-1
    Nishiyama Y; Fukuyama Y; Maruo T; Yoda S; Iwano M; Kawarai S; Kayanuma H; Orito K
    J Vet Med Sci; 2021 Aug; 83(8):1206-1211. PubMed ID: 34148911
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Comparison of the efficacy and safety of capecitabine or tegafur, gimeracil and oteracil potassium capsules combined with oxaliplatin chemotherapy regimens in the treatment of advanced gastric cancer].
    Wan Y; Hui H; Wang X; Wu J; Sun S
    Zhonghua Zhong Liu Za Zhi; 2016 Jan; 38(1):28-34. PubMed ID: 26796803
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impacts of evidence-based nursing combined with enteral nutrition on nutritional status and quality of life in acute cerebral infarction patients: A randomized controlled trial.
    Dang J; Li G; Wu Q; Pian G; Wang Z
    Perfusion; 2023 Dec; ():2676591231223910. PubMed ID: 38156428
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Observation on the Effect of Solution-Focused Approach Combined with Family Involvement in WeChat Platform Management on Inpatients with Intracerebral Hemorrhage.
    Song Y
    J Healthc Eng; 2022; 2022():9951374. PubMed ID: 35345652
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of quality control circle on nursing in orthopaedic trauma surgery.
    Yu J; Qi R; Wang W; Jiang G; Liu Y; Zhang W
    Am J Transl Res; 2022; 14(6):4380-4387. PubMed ID: 35836898
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tegafur + gimeracil + oteracil. Just another fluorouracil precursor.
    Prescrire Int; 2013 May; 22(138):122. PubMed ID: 23819172
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Feasibility study of adjuvant chemotherapy with S-1 (TS-1; tegafur, gimeracil, oteracil potassium) for gastric cancer.
    Kinoshita T; Nashimoto A; Yamamura Y; Okamura T; Sasako M; Sakamoto J; Kojima H; Hiratsuka M; Arai K; Sairenji M; Fukushima N; Kimura H; Nakajima T
    Gastric Cancer; 2004; 7(2):104-9. PubMed ID: 15224197
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A case of advanced cutaneous squamous cell carcinoma of the lower eyelid that was successfully treated with tegafur-gimeracil-oteracil potassium monotherapy.
    Yamamoto Y; Nakai N; Wakabayashi Y; Okuzawa Y; Asai J; Takenaka H; Katoh N
    J Am Acad Dermatol; 2012 Nov; 67(5):e233-4. PubMed ID: 23062933
    [No Abstract]   [Full Text] [Related]  

  • 15. Staged versus conventional nursing for patients receiving chemotherapy for advanced non-small cell lung cancer: a before and after study.
    Zhu L; Chen L; Kan H; Cai P
    Ann Palliat Med; 2021 Jan; 10(1):250-257. PubMed ID: 33474963
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evidence-based nursing intervention can improve the treatment compliance, quality of life and self-efficacy of patients with lung cancer undergoing radiotherapy and chemotherapy.
    Zhang T; Lu J; Fan Y; Wang L
    Am J Transl Res; 2022; 14(1):396-405. PubMed ID: 35173858
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of Tegafur, Gimeracil and Oteracil Potassium Capsules combined with Calf Spleen Extractive Injection on serum VEGF and MMP-9 in patients with advanced gastric cancer.
    Zhang Y; Zhong Q; Luo X; Zhang W
    Am J Transl Res; 2022; 14(11):7969-7976. PubMed ID: 36505301
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Eccrine squamous syringometaplasia of underlying syringoma associated with Tegafur/Gimeracil/Oteracil (TS-1).
    Kim J; Kim SH; Lee MG; Chung KY; Kim DS
    Acta Derm Venereol; 2015 Nov; 95(8):999-1000. PubMed ID: 25766447
    [No Abstract]   [Full Text] [Related]  

  • 19. Symptom and Quality of Life Improvement in LUX-Lung 8, an Open-Label Phase III Study of Second-Line Afatinib Versus Erlotinib in Patients With Advanced Squamous Cell Carcinoma of the Lung After First-Line Platinum-Based Chemotherapy.
    Felip E; Hirsh V; Popat S; Cobo M; Fülöp A; Dayen C; Trigo JM; Gregg R; Waller CF; Soria JC; Goss GD; Gordon J; Wang B; Palmer M; Ehrnrooth E; Gadgeel SM
    Clin Lung Cancer; 2018 Jan; 19(1):74-83.e11. PubMed ID: 28729180
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Recurrence of nivolumab-induced Stevens-Johnson syndrome due to tegafur/gimeracil/oteracil (TS-1®) after nivolumab discontinuation.
    Komatsu-Fujii T; Ogawa M; Nonoyama S; Fukumoto T; Tanabe H
    Eur J Dermatol; 2021 Feb; 31(1):98-99. PubMed ID: 33586655
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.